has anyone know where this new clinical trial is being held one shot shrinks prostate but it in trail not approved as yet but very promising so far google it!
I've been in contact with the company recently. They told me they have no upcoming trials. What did you hear?
Google said.
01. PII trials (1). · 02. PIII studies in US (3). ·
03. Feb 12: PIII study to start in EU [9]. ·
04. Feb 13: A Safety Monitoring Committee review highlighted no safety concerns [16]. ·
05. Apr 15: Recordati, the licensee in Europe, the Middle East, North Africa and South Africa, discontinued development and commercialisation activities in its licensed territories after two pivotal PIII trials for BPH conducted by Nymox failed to meet primary efficacy endpoints. Nymox expects to continue its development efforts for BPH in the US [23]. ·
06. Jul 15: Nymox now intends to meet with authorities with extension data and to proceed to file where possible in due course for regulatory approvals for fexapotide triflutate in various jurisdictions and territories [24]. ·
07. May 17: Nymox files for approval in five European countries, the Netherlands, UK, Germany, France and Spain [26]. ·
08. Jul 18: Nymox resubmits an expanded application, which replaces the previous applications [27]. ·
I was eagerly looking forward to this drug finally being approved. Last year, I thought it was dead in the water, but I just looked it up last week and it looks like they are still moving forward in trying to get FDA approval (they appear to be further along with EU approval).
Several years ago I remember seeing an article where the drug was stated as reducing the prostate size by about 20% in the first month. However, the latest articles primarily use IPSS as a criteria and prostate size reduction is not really mentioned. Having been in startups that went belly up myself, I know the desperation of company founders when a company is going under. Only the most positive results are put forth and often greatly embellished.
At any rate, I am still hopeful, but,,,,,,,,,,,
i would like more information sounds great
There are certainly conflicting reports on the drug and on Nymox, the company marketing it. The marketing claims sound good but you would think that men who have been treated would be speaking up about their results.
Urologists will not like it :-)
Not sure why you say that, Derek. Urologists will be the ones performing the injections. It probably won't be cheap. Also, the studies I've ready recently talk about multiple injections.
While it will probably be less expensive than the other procedures, it will be a treatment under their control as opposed to FLA and PAE.
"The marketing claims sound good but you would think that men who have been treated would be speaking up about their results."
Yes! The same thought occurred to me about a week ago when I was looking at FT studies. I actually tried to search for comments made by men who were part of the studies, but could not find anything. My guess is that the men were required to sign a non-disclosure agreement. If FT lives up to its billing, it would be a terrific advancement. However, there are so many questions about the company and what seems like covering up less than glowing information/reports.
The most interesting no side effect treatment I've heard of since PAE - no heat sounds like the holy grail if it's true. I wrote to professor in Colorado (where I live) who hosted a video on the test results to ask him if he does it yet.
Here are two articles that I found last week. They are similar articles as far as I could tell. So many of the authors have conflicts of interest.
https://www.ncbi.nlm.nih.gov/pubmed/29380128
https://www.ncbi.nlm.nih.gov/pubmed/30719081
thank you i hope its approved
Perhaps silence was their price for being included in the trials.
I would think that others than urologists could do it. The price and who gets to do it will be controlled by the drug company.
Hi, if it shrinks ones prostate what else does it shrink that they don't want to tell you about? drugs I hope one day there will be harmless drugs that work.
From what I read, the shots are now directed into the transition zone. Maybe you're right, but I would want someone with an intimate knowledge of the anatomy to shoot me up.
My understanding is that they have injected the drug into other organs and tissue that are near the prostate of rats and dogs. Supposedly, in all cases, there were no negative effects.
its injected directly into prostate why would you worry and weren't they followed for 3 years? they can't lie about results in a study. They reported no side effects - anything else shrinking would be a side effect What i didn't see was median lobe mentioned.
I've been watching this drug for about a year. If I recall, the drug is activated by the PSA produced in the prostate. It causes cell death but only prostate cells. There is another drug called topsalysin. Recent Information is kind of hard to find. If you stumble on something post it up. If your post gets "moderated" please PM me.
I read cell death but is that shrinkage or a hole in the tissue ?